Cost Plus Drugs CEO Alex Oshmyansky TK on the latest episode of the “Rapid Response” podcast.

While antiviral drugs to treat HIV had been approved a decade earlier, only five out of 33 million people who carried the ...

At a time when geopolitical tensions are hitting industries from semiconductors to electric vehicles, pharmaceutical ...

Some of the world's largest hedge funds are hiring doctors, scientists and analysts to give them expert insight into the ...

Artificial intelligence is changing the way industries do business. But executives in the pharmaceutical industry are still ...

Failed to fetch dynamically imported module: https://finance.yahoo.com/assets/_app/immutable/nodes/90.nXY4Viq9.js ...

The last few years have been marked by many big pharma companies opting to move away from diversification and towards more focused operations. Ben Hargreaves explores what is driving this ...

After three years of mounting pressure from AIDS activists, the pharma companies finally dropped their case. While this story has a happy ending, Mandela’s battle against Big Pharma was only a ...

The choice of outsourcing operating model(s) and the executive governance to implement the model(s) of choice are critical decisions for R&amp,D leadership teams in Big Pharma companies.

One company is determined to improve drug development success rates, and its cell simulation platform is already being used ...